EDTA Studies

  1. Guldager, B., Jelsnes, R., Jorgensen, S.J., et al, “EDTA Treatment of Intermittent Claudication – A Double-Blind, Placebo Controlled Study.“, Journal of Internal Medicine, 1992.
  2. Chappell, M.D., L. Terry & Stahl, Ph.D., John P., “The Correlation Between EDTA Chelation Therapy and Improvement in Cardiovascular Function: A Meta-Analysis“, Journal of Advancement in Medicine. Fall 1993.
  3. Olszewer, M.D., Efrain & Carter, M.D., Ph.D., James P., “EDTA Chelation Therapy: A Retrospective Study of 2,870 Patients“, Journal of Advancement in Medicine, Spring/Summer 1989.
  4. Olszewer, M.D., E., Carter, M.D., Ph.D., J.P. & Sabbag, F.C., “A Pilot Double-Blind Study of Sodium-Magnesium EDTA In Peripheral Vascular Disease“, The National Medical Journal, March, 1990.
  5. Rudolph, D.O., Ph.D., C.J., McDonagh, D.O., A.C.G.P., E.W. & Barber, B.S., A.C.S.M., E.T.T., R.K., “A Nonsurgical Approach to Obstructive Carotid Stenosis Using EDTA Chelation“, Journal of Advancement in Medicine, Fall 1991.
  6. Hancke, M.D., C. & Flytlie, M.D., K., “Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective Study of 470 Patients“, Journal of Advancement in Medicine, Fall 1993.
  7. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M.Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004 Apr 6;140(7):533-7.
  8. Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered vitamin C as cancer therapy: three cases.CMAJ. 2006 Mar 28;174(7):937-42.
  9. Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J. 2008 Mar;27(1):7-19. Review.
  10. Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005 Dec;24(4):269-76.
  11. Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J. 2004 Jun;23(2):115-8.
  12. Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients’ health-related quality of life after high dose vitamin C administration. J Korean Med Sci. 2007 Feb;22(1):7-11.